FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

PHASE4CompletedINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2017

Conditions
Infertility
Interventions
DRUG

Urofollitrophin

DRUG

Follitrophin alpha

Trial Locations (16)

8028

Institut Universitari Dexeus, Barcelona

40011

Instituto Valenciano de Infertilidad (IVI), Seville

Unknown

UCL- Cliniques Universitaires Saint Luc, Brussels

Universitair Ziekenhuis Brussel, Brussels

Spedali Civili di Brescia, Brescia

Fondazione Ca'Granda, Osp Maggiore Policlinico, Milan

IRCCS San Raffaele, Milan

Università degli Studi di Napoli 'Federico II', Naples

Azienda Ospedaliera Di Reggio Emilia, Reggio Emilia

Ginefiv Clínica de Fertilidad, Madrid

Universitäts-Frauenklinik, Basel

Universitätsklinik für Frauenheilkunde, Bern

Prof. Bülent Urman, Istanbul

Ege University, Izmir

Midland Fertility Services, Aldridge

03015

Clinica IVI Alicante, Alicante

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT01969201 - FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) | Biotech Hunter | Biotech Hunter